John Reid, formerly chief executive of the Sanford-Burnham Medical Research Institute in La Jolla, California, has been appointed head of Roche Pharma Research and Early Development and a member of the enlarged corporate executive committee. He will report to Severin Schwan, the group chief executive.
Dr Reed earned his medical degree and PhD at the School of Medicine of the University of Pennsylvania and is an expert on cancer, neuroprotection, autoimmunity and other diseases. He is the founder or co-founder of a number of biotechnology companies as well as the holder of more than 100 hundred patents. He will be based in Basel and assume his new role on 2 April 2013.
The Roche Group announced the appointment on 15 January 2013.
Copyright 2013 Evernow Publishing Ltd.